HEMISPHERX BIOPHARMA GETS DNA-BASED VACCINE PRODUCTION LICENSE

Philadelphia-based biopharma major Hemispherx Biopharma has announced the worldwide exclusive licensure of its international patent estate developed at Vanderbilt University for in vivo use of the chemical compound dioctadecylamidoglycylspermine (DOGS) for the efficient delivery of therapeutic DNA to the interior of cells.
BioSpectrum